DrugPatentWatch Database Preview
Merz Pharms Company Profile
Email this page to a colleague
» See Plans and PricingUS Patents for Merz Pharms
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 9,764,011 | Allergan, Inc. (Irvine, CA) | 2030-03-30 | RX | search | |
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 9,662,450 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2029-05-13 | RX | search | |
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 9,554,968 | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 9,279,001 | Allergan, Inc. (Irvine, CA) | 2030-03-30 | RX | search | |
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 8,685,381 | 2030-10-23 | RX | search | ||
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 8,568,741 | 2039-03-29 | RX | search | ||
| Merz Pharms | XEOMIN | incobotulinumtoxina | INJECTABLE; INJECTION | 125360 | 002 | 2010-07-30 | 10,406,213 | Allergan, Inc. (Irvine, CA) | 2030-03-30 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
